(Photo by Wes Tank)

Milwaukee Neighborhood News Service invites community members to submit opinion pieces of 500-800 words on topics of interest to central city Milwaukee. To send a submission for consideration, please email info@milwaukeenns.org. The views expressed are solely those of the authors.

In just a few weeks, I’ll be taking part in the inaugural Audaxity Ride, a bold and inspiring cycling event dedicated to one mission: ending cancer in our lifetime. 

Advertisement
Community Voices logo

This cause is deeply personal to me, and I’m reaching out to ask for your support.

On Aug. 17, alongside my team—the Cell Cyclers—I’ll be hitting the road to raise critical funds for cancer research at the Medical College of Wisconsin Cancer Center. 

Some of us will ride 5 miles, others 25, 50, or even 100. But every pedal stroke is driven by the same purpose: to fuel innovative research, improve treatment options, and bring hope to patients and families everywhere.

Gustavo W. Leone (Photo provided by Medical College of Wisconsin)

What makes this effort especially meaningful is that 100% of every donation goes directly to cancer research—no overhead, no fees. Your gift, no matter the size, is both deeply appreciated and fully tax-deductible.

If you’d like to support our team, please visit our page and click “Support Us.”

I am privileged to work with an extraordinary community of more than 1,000 scientists, clinicians, trainees, and staff who dedicate their lives to defeating cancer—from common diagnoses like leukemia and breast cancer to rare and devastating forms affecting children. 

On that day, they won’t just be in the lab or the clinic—they’ll be on bicycles, riding through the streets and countryside of Wisconsin with passion, perseverance, and purpose.

Thank you for considering a donation and for standing with us in the fight against cancer. Your support means the world.


Gustavo W. Leone serves as the director of the Medical College of Wisconsin Cancer Center.

Creative Commons License

Republish our articles for free, online or in print, under a Creative Commons license.